Premier Biomedical, Inc. (OTCPK:BIEI) announced that it has entered into an equity line private placement with new accredited investor, Green Coast Capital International SA for gross proceeds of $5,000,000 on September 26, 2019. The company will issue common shares as securities in the transaction. The company and the investor entered into a equity purchase agreement as part of the transaction. The company will issue a put notice to the investor to purchase its common stock at a 10% discount to the lowest trade price of its common stock during the 5 trading days immediately following the clearing date associated with the put notice and in an amount of the lesser of either $1,000,000 or 200% of the average daily trading volume of its common stock in the 10 trading days immediately preceding the date we give notice to the investor. The company may issue multiple put notices to the investor, subject to these limitations, but may not issue a put notice to the investor within 10 trading days of a prior notice. The commitment period for the agreement will commence on the execution date of the agreement and end on the earlier of the date on which the Investor shall have purchased put shares equal to the maximum commitment amount or September 26, 2022 or by a written notice of termination by the company to the investor. The clearing costs as part of the transaction will be the investor’s broker and transfer agent fees, excluding commissions, up to a maximum of $500 per put.